Skip to main content

and
  1. No Access

    Article

    Examining the clinical and radiological landscape of rhupus: navigating the challenges in disease classification

    Rhupus, in the broad sense, refers to an overlap between rheumatoid arthritis (RA) and lupus. However, there is a paucity of data on the appropriate diagnostic/classification criteria that should be used to de...

    Aliya Botabekova, Chokan Baimukhamedov, Olena Zimba in Rheumatology International (2024)

  2. No Access

    Article

    Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial

    Curcumin has anti-inflammatory properties but current evidence is limited to advocate its use in rheumatoid arthritis (RA). We explored whether curcumin could maintain remission in patients with RA while taper...

    Sreeja S. Bhat, Sakir Ahmed, Reshma Reji, Pankti Mehta in Rheumatology International (2023)

  3. No Access

    Article

    Long-standing and poorly controlled disease in juvenile dermatomyositis is associated with calcinosis: a real-world experience from a low-middle income country

    To study the prevalence and predictors of calcinosis in Juvenile Dermatomyositis (JDM). Medical records over 20 years at a tertiary care rheumatology center in Northern India were reviewed to identify patients...

    Pankti Mehta, Able Lawrence, Latika Gupta, Durga P. Misra in Rheumatology International (2023)

  4. Article

    Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic diseases

    Data on the effectiveness of SARS-CoV-2 vaccines and the durability of protection against the prevalent Omicron variant are scarce, especially in patients with autoimmune rheumatic diseases (AIRDs). Hence, we ...

    Libin Benny, Pankti Mehta, Sakir Ahmed, Aby Paul in Rheumatology International (2023)

  5. Article

    Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity

    Patients with autoimmune rheumatic diseases with a previous infection by the SARS-CoV-2 virus have exaggerated responses to a single dose of COVID-19 vaccination as compared to fully vaccinated infection naive...

    Aparna R. Menon, Somy Cherian, Aby Paul, Kripesh Kumar in Rheumatology International (2023)

  6. No Access

    Article

    Diagnostic accuracy of antineutrophil cytoplasmic antibodies (ANCA) in predicting relapses of ANCA-associated vasculitis: systematic review and meta-analysis

    Relapse in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) is associated with significant morbidity and mortality. Utility of ANCA for prediction of relapses is still controversial. Pu...

    Pankti Mehta, Anu Balakrishnan, Sanat Phatak, Mona Pathak in Rheumatology International (2023)

  7. Article

    Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses

    Outcomes of COrona VIrus Disease-19 (COVID-19) in patients with rheumatic diseases (RDs) reported in various studies are heterogenous owing to the influence of age and comorbidities which have a significant be...

    Pankti Mehta, Armen Yuri Gasparyan, Olena Zimba, George D. Kitas in Clinical Rheumatology (2022)

  8. Article

    Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease

    There is paucity of data on extended dosing interval between two doses of AZD1222 (AstraZeneca) in patients with Autoimmune Rheumatic Diseases (AIRD). We aimed to study the humoral response and rate of breakth...

    Pankti Mehta, Aby Paul, Sakir Ahmed, Somy Cherian, Ameya Panthak in Clinical Rheumatology (2022)

  9. No Access

    Article

    Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort

    On the background of a restricted armamentarium of drugs available for the management of fibromyalgia (FM), we aimed to compare the real-world effectiveness of two serotonin-norepinephrine reuptake inhibitors ...

    Pankti Mehta, Amartya Basu, Sakir Ahmed in Rheumatology International (2022)

  10. Article

    Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management

    Patients with systemic lupus erythematosus (SLE) form a vulnerable group in terms of the impact of the COVID-19 pandemic on disease management. We conducted this overview by searches through Medline/PubMed, Sc...

    Pankti Mehta, Armen Yuri Gasparyan, Olena Zimba, George D. Kitas in Clinical Rheumatology (2022)

  11. Article

    Juvenile dermatomyositis with gingival vasculopathy

    Hiba Khan, Pankti Mehta, Latika Gupta in Clinical Rheumatology (2021)

  12. Article

    Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry

    Anti-Melanoma Differentiation-Associated gene 5 (MDA-5) Dermatomyositis (MDA5, DM) is a recently identified subtype of myositis characteristically associated with Rapidly Progressive Interstitial Lung Disease ...

    Pankti Mehta, Pedro M. Machado, Latika Gupta in Rheumatology International (2021)